Testing a new wart cream for kids ages 8 to 18
Part of Infections, Skin clinical trials.
This study is testing an ointment called tirbanibulin to treat warts on the hands of children and teens. It may offer a new option if other treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 18 years old.
- You have warts only on your hands (not elsewhere on your body).
- You have between 3 and 10 warts on your hands.
- Your warts have been present for 2 years or less.
- You haven't used any wart treatments (creams, procedures) in the last 6 weeks.
- You are generally healthy and not taking medications that weaken your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream combination of 5-fluorouracil and calcipotriol for children with warts on their hands or feet. It may offer a more effective treatment option for stubborn warts.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
This study tests whether cantharidin—a liquid applied directly to common warts—can safely and effectively remove them. Common warts are bumpy growths caused by a virus that appear on hands, feet, and other body areas.
This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.
Hear when a new Warts Hand trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.